Found 127 matching trials
Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma PHASE2 The investigators conducted a phase II, prospective, two-arm clinical study...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer. PHASE2 This is a prospective single-arm exploratory clinical study. The efficacy a...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping. N/A Extensive research employing diverse omics methodologies has unveiled a var...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy. PHASE3 This prospective trial aims to enroll patients with stage III-IVA (AJCC 8th...
Show More Location
The Fifth Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Camrelizumab as a Maintenance Therapy After Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma PHASE2 The purpose of this study was to evaluate the efficacy and safety of Camrel...
Show More Location
Cancer hospital, Chineses Academy of Medical Sciences
Learn More & Join Trial
Total Neoadjuvant Treatment ±Immunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi) PHASE3 The goal of this clinical trial is to compare the PCR rate between Total Ne...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Camrelizumab, Pirfenidone, and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer PHASE1 This is a prospective, single-arm, exploratory clinical study, planned to e...
Show More Location
Multiple Locations
Learn More & Join Trial
Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients PHASE2 Lung cancer is the cancer with the highest morbidity and mortality among me...
Show More Location
Hubei Cancer Hospital
Learn More & Join Trial
A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification PHASE3 This study was designed to evaluate the effectiveness and safety of hepatic...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Camrelizumab Combination With SBRT and Concurrent Chemotherapy Treated Stage IV Oligometastatic Non-small Cell Lung Cancer PHASE2 This study evaluated the effectiveness and safety of Camrelizumab combinati...
Show More Location
Sichuan Cancer Hospital & Institute
Learn More & Join Trial